Evidence map›Paper›PMID 30358021›Full record

ArticleStem cells (Dayton, Ohio)2019

Human Cartilage-Derived Progenitors Resist Terminal Differentiation and Require CXCR4 Activation to Successfully Bridge Meniscus Tissue Tears.

Chathuraka T Jayasuriya, John Twomey-Kozak, Jake Newberry, Salomi Desai, Peter Feltman, Jonathan R Franco, Neill Li, Richard Terek, Michael G Ehrlich, Brett D Owens

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Extracellular vesicles from cartilage progenitors stimulate type II collagen expression and wound healing in meniscal cells.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Suppressing Chondrocyte Hypertrophy to Build Better Cartilage.Bioengineering (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Meniscus Regeneration With Multipotent Stromal Cell Therapies.Frontiers in bioengineering and biotechnology · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chathuraka T JayasuriyaDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.ORCID 0000-0002-2705-0679
John Twomey-KozakDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Jake NewberryDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Salomi DesaiDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Peter FeltmanDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Jonathan R FrancoDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Neill LiDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Richard TerekDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Michael G EhrlichDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Brett D OwensDepartment of Orthopaedics, Brown University/Rhode Island Hospital, Providence, Rhode Island, USA.
Brown University · US

Funding

Tracking and Evaluation CoreU54GM115677 · NIGMS · BROWN UNIVERSITY · PI KOGUT, STEPHEN J · 2016 to 2025
$45.0M
Pilot Projects ProgramP30GM122732 · NIGMS · RHODE ISLAND HOSPITAL · PI CHEN, QIAN · 2017 to 2021
$6.6M
NIGMS NIH HHS P30 GM122732NIGMS NIH HHS U54 GM115677
6 · The paper itself

Abstract

Meniscus injuries are among the most common orthopedic injuries. Tears in the inner one-third of the meniscus heal poorly and present a significant clinical challenge. In this study, we hypothesized that progenitor cells from healthy human articular cartilage (chondroprogenitor cells [C-PCs]) may be more suitable than bone-marrow mesenchymal stem cells (BM-MSCs) to mediate bridging and reintegration of fibrocartilage tissue tears in meniscus. C-PCs were isolated from healthy human articular cartilage based on their expression of mesenchymal stem/progenitor marker activated leukocyte cell adhesion molecule (ALCAM) (CD166). Our findings revealed that healthy human C-PCs are CD166+, CD90+, CD54+, CD106- cells with multilineage differentiation potential, and elevated basal expression of chondrogenesis marker SOX-9. We show that, similar to BM-MSCs, C-PCs are responsive to the chemokine stromal cell-derived factor-1 (SDF-1) and they can successfully migrate to the area of meniscal tissue damage promoting collagen bridging across inner meniscal tears. In contrast to BM-MSCs, C-PCs maintained reduced expression of cellular hypertrophy marker collagen X in monolayer culture and in an explant organ culture model of meniscus repair. Treatment of C-PCs with SDF-1/CXCR4 pathway inhibitor AMD3100 disrupted cell localization to area of injury and prevented meniscus tissue bridging thereby indicating that the SDF-1/CXCR4 axis is an important mediator of this repair process. This study suggests that C-PCs from healthy human cartilage may potentially be a useful tool for fibrocartilage tissue repair/regeneration because they resist cellular hypertrophy and mobilize in response to chemokine signaling. Stem Cells 2019;37:102-114.

Indexed as

AnimalsCartilage, ArticularCell DifferentiationChondrogenesisHumansMeniscusRatsReceptors, CXCR4CXCR4 protein, humanReceptors, CXCR4CartilageChondroprogenitorHypertrophyMeniscusProgenitorStem cellTissue repair

Identifiers

PMID30358021
PMCPMC6312732
OpenAlexW2898289324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.